These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7635916)

  • 1. An approach to antiretroviral treatment of HIV disease. Individualized therapy: the role of viral-burden measures.
    Thompson MA
    Hosp Pract (1995); 1995 Aug; 30 Suppl 1():41-50. PubMed ID: 7635916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volunteers needed for study of HIV viral load test.
    Oncology (Williston Park); 1996 Apr; 10(4):449-50. PubMed ID: 8723276
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative virological measures of antiretroviral therapy.
    Katzenstein DA; Holodniy M
    AIDS Clin Rev; 1992; ():41-67. PubMed ID: 1376615
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival and disease progression in 251 patients with HIV-1 infection. Study of p24 antigen and viral burden as prognosis makers. Their value at 4 years of follow-up].
    Rubio Caballero M; Rubio Rivas C; Nogués Biau A; Falguera Sacrest M; Manonelles Fernández A
    An Med Interna; 2001 Oct; 18(10):517-20. PubMed ID: 11766280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
    Sterling TR; Hoover DR; Astemborski J; Vlahov D; Bartlett JG; Schupbach J
    J Infect Dis; 2002 Oct; 186(8):1181-5. PubMed ID: 12355373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies for quantifying HIV: amplification assays directly measure the virus at all stages of infection.
    J Int Assoc Physicians AIDS Care; 1995 Nov; 1(10):14-5. PubMed ID: 11362970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and virological markers in HIV infection.
    Vella S
    AIDS Clin Care; 1995 May; 7(5):37-40. PubMed ID: 11362683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and access to viral load measure assays: the need for validation.
    Agosto M
    Update Natl Minor AIDS Counc; 1995; ():7-8. PubMed ID: 11362791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral load and response to treatment of HIV.
    De Gruttola V; Fleming T; Coombs R
    N Engl J Med; 1996 Jun; 334(25):1671-2; author reply 1672-3. PubMed ID: 8628373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Virological diagnosis of HIV infection in children].
    Muñoz Fernández MA
    Allergol Immunopathol (Madr); 1998; 26(3):122-9. PubMed ID: 9675394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic value of virology and immunology markers in Chinese HIV-1 infected people].
    Lin X; Xu L; Shao Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):41-4. PubMed ID: 12759951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T
    An Med Interna; 1999 Sep; 16(9):447-50. PubMed ID: 10609356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.
    Trøseid M; Nowak P; Nyström J; Lindkvist A; Abdurahman S; Sönnerborg A
    AIDS; 2010 Jul; 24(11):1733-7. PubMed ID: 20502315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
    Mildvan D; Bassiakos Y; Zucker ML; Hyslop N; Krown SE; Sacks HS; Zachary J; Paredes J; Fessel WJ; Rhame F; Kramer F; Fischl MA; Poiesz B; Wood K; Ruprecht RM; Kim J; Grossberg SE; Kasdan P; Bergé P; Marshak A; Pettinelli C
    Antivir Ther; 1996 Apr; 1(2):77-88. PubMed ID: 11321183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualization of therapy using viral markers.
    Merigan T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S41-6. PubMed ID: 8595507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.